vs
EAGLE MATERIALS INC（EXP）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是EAGLE MATERIALS INC的1.4倍（$772.1M vs $556.0M），EAGLE MATERIALS INC净利率更高（18.5% vs 12.7%，领先5.8%），Revvity同比增速更快（5.9% vs -0.4%），Revvity自由现金流更多（$161.8M vs $60.8M），过去两年Revvity的营收复合增速更高（9.0% vs 8.0%）
Eagle Materials Inc.是总部位于美国得克萨斯州达拉斯的建筑材料生产企业，主营产品包括水泥、混凝土、建筑骨料、石膏、墙板、纸板以及水力压裂作业专用砂，产品广泛应用于建筑施工、能源开发等多个领域。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
EXP vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.4倍
$556.0M
营收增速更快
RVTY
高出6.2%
-0.4%
净利率更高
EXP
高出5.8%
12.7%
自由现金流更多
RVTY
多$101.0M
$60.8M
两年增速更快
RVTY
近两年复合增速
8.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $556.0M | $772.1M |
| 净利润 | $102.9M | $98.4M |
| 毛利率 | 28.9% | — |
| 营业利润率 | — | 14.5% |
| 净利率 | 18.5% | 12.7% |
| 营收同比 | -0.4% | 5.9% |
| 净利润同比 | -13.9% | 3.9% |
| 每股收益（稀释后） | $3.22 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPRVTY
| Q4 25 | $556.0M | $772.1M | ||
| Q3 25 | $638.9M | $698.9M | ||
| Q2 25 | $634.7M | $720.3M | ||
| Q1 25 | $470.2M | $664.8M | ||
| Q4 24 | $558.0M | $729.4M | ||
| Q3 24 | $623.6M | $684.0M | ||
| Q2 24 | $608.7M | $691.7M | ||
| Q1 24 | $476.7M | $649.9M |
净利润EXPRVTY
| Q4 25 | $102.9M | $98.4M | ||
| Q3 25 | $137.4M | $46.7M | ||
| Q2 25 | $123.4M | $53.9M | ||
| Q1 25 | $66.5M | $42.2M | ||
| Q4 24 | $119.6M | $94.6M | ||
| Q3 24 | $143.5M | $94.4M | ||
| Q2 24 | $133.8M | $55.4M | ||
| Q1 24 | $77.1M | $26.0M |
毛利率EXPRVTY
| Q4 25 | 28.9% | — | ||
| Q3 25 | 31.3% | 53.6% | ||
| Q2 25 | 29.2% | 54.5% | ||
| Q1 25 | 22.2% | 56.5% | ||
| Q4 24 | 31.9% | — | ||
| Q3 24 | 32.7% | 56.3% | ||
| Q2 24 | 30.7% | 55.7% | ||
| Q1 24 | 25.1% | 54.6% |
营业利润率EXPRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | 32.8% | 16.3% | ||
| Q3 24 | 34.2% | 14.3% | ||
| Q2 24 | 32.0% | 12.4% | ||
| Q1 24 | 26.9% | 6.8% |
净利率EXPRVTY
| Q4 25 | 18.5% | 12.7% | ||
| Q3 25 | 21.5% | 6.7% | ||
| Q2 25 | 19.4% | 7.5% | ||
| Q1 25 | 14.1% | 6.4% | ||
| Q4 24 | 21.4% | 13.0% | ||
| Q3 24 | 23.0% | 13.8% | ||
| Q2 24 | 22.0% | 8.0% | ||
| Q1 24 | 16.2% | 4.0% |
每股收益（稀释后）EXPRVTY
| Q4 25 | $3.22 | $0.86 | ||
| Q3 25 | $4.23 | $0.40 | ||
| Q2 25 | $3.76 | $0.46 | ||
| Q1 25 | $2.01 | $0.35 | ||
| Q4 24 | $3.56 | $0.77 | ||
| Q3 24 | $4.26 | $0.77 | ||
| Q2 24 | $3.94 | $0.45 | ||
| Q1 24 | $2.23 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $419.0M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $7.3B |
| 总资产 | $3.8B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXPRVTY
| Q4 25 | $419.0M | $919.9M | ||
| Q3 25 | $35.0M | $931.4M | ||
| Q2 25 | $59.7M | $991.8M | ||
| Q1 25 | $20.4M | $1.1B | ||
| Q4 24 | $31.2M | $1.2B | ||
| Q3 24 | $93.9M | $1.2B | ||
| Q2 24 | $46.5M | $2.0B | ||
| Q1 24 | $34.9M | $1.7B |
总债务EXPRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.1B | — |
股东权益EXPRVTY
| Q4 25 | $1.5B | $7.3B | ||
| Q3 25 | $1.5B | $7.4B | ||
| Q2 25 | $1.5B | $7.6B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.5B | $7.7B | ||
| Q3 24 | $1.4B | $7.9B | ||
| Q2 24 | $1.4B | $7.9B | ||
| Q1 24 | $1.3B | $7.8B |
总资产EXPRVTY
| Q4 25 | $3.8B | $12.2B | ||
| Q3 25 | $3.4B | $12.1B | ||
| Q2 25 | $3.4B | $12.4B | ||
| Q1 25 | $3.3B | $12.4B | ||
| Q4 24 | $3.0B | $12.4B | ||
| Q3 24 | $3.1B | $12.8B | ||
| Q2 24 | $3.0B | $13.4B | ||
| Q1 24 | $2.9B | $13.4B |
负债/权益比EXPRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.84× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $60.8M | $161.8M |
| 自由现金流率自由现金流/营收 | 10.9% | 21.0% |
| 资本支出强度资本支出/营收 | 19.8% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.66× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $231.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流EXPRVTY
| Q4 25 | $170.8M | $182.0M | ||
| Q3 25 | $204.6M | $138.5M | ||
| Q2 25 | $136.6M | $134.3M | ||
| Q1 25 | $62.8M | $128.2M | ||
| Q4 24 | $119.9M | $174.2M | ||
| Q3 24 | $233.3M | $147.9M | ||
| Q2 24 | $132.6M | $158.6M | ||
| Q1 24 | $63.4M | $147.6M |
自由现金流EXPRVTY
| Q4 25 | $60.8M | $161.8M | ||
| Q3 25 | $96.1M | $120.0M | ||
| Q2 25 | $60.5M | $115.5M | ||
| Q1 25 | $14.5M | $112.2M | ||
| Q4 24 | $72.5M | $149.8M | ||
| Q3 24 | $166.8M | $125.6M | ||
| Q2 24 | $99.5M | $136.6M | ||
| Q1 24 | $30.9M | $129.7M |
自由现金流率EXPRVTY
| Q4 25 | 10.9% | 21.0% | ||
| Q3 25 | 15.0% | 17.2% | ||
| Q2 25 | 9.5% | 16.0% | ||
| Q1 25 | 3.1% | 16.9% | ||
| Q4 24 | 13.0% | 20.5% | ||
| Q3 24 | 26.7% | 18.4% | ||
| Q2 24 | 16.3% | 19.7% | ||
| Q1 24 | 6.5% | 20.0% |
资本支出强度EXPRVTY
| Q4 25 | 19.8% | 2.6% | ||
| Q3 25 | 17.0% | 2.6% | ||
| Q2 25 | 12.0% | 2.6% | ||
| Q1 25 | 10.3% | 2.4% | ||
| Q4 24 | 8.5% | 3.4% | ||
| Q3 24 | 10.7% | 3.3% | ||
| Q2 24 | 5.4% | 3.2% | ||
| Q1 24 | 6.8% | 2.7% |
现金转化率EXPRVTY
| Q4 25 | 1.66× | 1.85× | ||
| Q3 25 | 1.49× | 2.97× | ||
| Q2 25 | 1.11× | 2.49× | ||
| Q1 25 | 0.94× | 3.03× | ||
| Q4 24 | 1.00× | 1.84× | ||
| Q3 24 | 1.63× | 1.57× | ||
| Q2 24 | 0.99× | 2.87× | ||
| Q1 24 | 0.82× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXP
| External Customers | $283.5M | 51% |
| Gypsum Wallboard | $175.9M | 32% |
| Recycled Paperboard | $47.8M | 9% |
| Corporate Joint Venture | $29.4M | 5% |
| Other | $11.8M | 2% |
| Western Pennsylvania Acquisition | $7.6M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
